Radiopharmaceuticals for therapy

0Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Common radionuclides used for radiometabolic therapy include 131I, 153Sm, 89Sr, 223Ra, and 90Y. In this chapter we will focus on therapeutic radiopharmaceuticals are employed for therapy of differentiated follicular thyroid carcinomas, for therapy of pheochromocytoma/paraganglioma/ neuroblastomas, for bone pain palliation, for radioimmunotherapy of lymphomas, for peptide radioreceptor therapy of neuroendocrine tumors, and for intra-arterial radioembolization of hypervascularized tumors of the liver.

Cite

CITATION STYLE

APA

Orsini, F., Mazzarri, S., Puta, E., Guidoccio, F., Lorenzoni, A., & Mariani, G. (2017). Radiopharmaceuticals for therapy. In Nuclear Oncology: From Pathophysiology to Clinical Applications (pp. 99–113). Springer International Publishing. https://doi.org/10.1007/978-3-319-26236-9_34

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free